Understanding sedative effects within the context of acute neuroinflammation in the developing brain: Potential

Amanda Furman1, Nikki Miller Ferguson2, Audrey D Lafrenaye3

  • 1Department of Physical Medicine and Rehabilitation, Richmond, VA, United States.

PubMed

Insights

Pediatric critical illness can cause delirium. Combining inflammation with opioid and benzodiazepine sedation in young rats worsened delirium-like behaviors and altered neuroinflammation markers.

Area of Science:

  • Neuroscience
  • Pediatric Critical Care
  • Pharmacology

Background:

  • Neurologic morbidity is common in critically ill children.
  • Opioid and benzodiazepine sedation is a risk factor for delirium and long-term issues.
  • The interaction between multidrug sedation and brain inflammation in pediatric critical illness is understudied.

Purpose of the Study:

  • To investigate the combined effects of inflammation and multidrug sedation (opioids and benzodiazepines) on neuroinflammation and delirium-like behaviors in developing rats.
  • To understand the impact on neuroimmune responses and neurodevelopment.

Main Methods:

  • Mild-moderate inflammation was induced using lipopolysaccharide (LPS) in weanling rats.
  • Rats received repeated opioid (morphine) and benzodiazepine (midazolam) sedation.
  • Delirium-like behaviors were assessed using a composite z-score, and neuroinflammatory markers (Iba1, GFAP) and cytokines were measured in brain homogenates.

Main Results:

  • LPS, MorMdz, or LPS/MorMdz treatments significantly increased delirium-like behaviors compared to controls.
  • While LPS alone increased neuroinflammatory markers and cytokines, co-administration with MorMdz did not show the same increase.
  • Specifically, ionized calcium-binding adaptor molecule 1 (Iba1) and glial fibrillary acidic protein (GFAP) expression was higher after LPS than LPS/MorMdz.

Conclusions:

  • Combined inflammation and multidrug sedation in developing rats exacerbates delirium-like behaviors.
  • This combination may modulate the neuroinflammatory response, potentially masking some effects of inflammation alone.
  • Findings highlight the need to consider sedation's impact on neuroimmune responses in pediatric critical illness.

Related Concept Videos

CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
350
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
205
Depressants01:28

Depressants

Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
145
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
478
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
287
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
351